BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20589832)

  • 1. Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.
    Perez RE; Knights CD; Sahu G; Catania J; Kolukula VK; Stoler D; Graessmann A; Ogryzko V; Pishvaian M; Albanese C; Avantaggiati ML
    J Cell Physiol; 2010 Nov; 225(2):394-405. PubMed ID: 20589832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
    Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
    Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id4 dependent acetylation restores mutant-p53 transcriptional activity.
    Knowell AE; Patel D; Morton DJ; Sharma P; Glymph S; Chaudhary J
    Mol Cancer; 2013 Dec; 12():161. PubMed ID: 24330748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil.
    Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR
    Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.
    Watts GS; Oshiro MM; Junk DJ; Wozniak RJ; Watterson S; Domann FE; Futscher BW
    Neoplasia; 2004; 6(3):187-94. PubMed ID: 15153330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress.
    Mazzà D; Infante P; Colicchia V; Greco A; Alfonsi R; Siler M; Antonucci L; Po A; De Smaele E; Ferretti E; Capalbo C; Bellavia D; Canettieri G; Giannini G; Screpanti I; Gulino A; Di Marcotullio L
    Cell Death Differ; 2013 Dec; 20(12):1688-97. PubMed ID: 24013724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.
    Liu Y; Colosimo AL; Yang XJ; Liao D
    Mol Cell Biol; 2000 Aug; 20(15):5540-53. PubMed ID: 10891493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
    Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
    J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.
    Dell'Orso S; Fontemaggi G; Stambolsky P; Goeman F; Voellenkle C; Levrero M; Strano S; Rotter V; Oren M; Blandino G
    OMICS; 2011 May; 15(5):305-12. PubMed ID: 21332394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIAH-mediated ubiquitination and degradation of acetyl-transferases regulate the p53 response and protein acetylation.
    Grishina I; Debus K; García-Limones C; Schneider C; Shresta A; García C; Calzado MA; Schmitz ML
    Biochim Biophys Acta; 2012 Dec; 1823(12):2287-96. PubMed ID: 23044042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
    Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
    Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
    Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
    Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.
    Vaughan CA; Singh S; Windle B; Sankala HM; Graves PR; Andrew Yeudall W; Deb SP; Deb S
    Arch Biochem Biophys; 2012 Feb; 518(1):79-88. PubMed ID: 22198284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetyltransferase promotes fluoride toxicity in LS8 cells.
    Deng H; Fujiwara N; Cui H; Whitford GM; Bartlett JD; Suzuki M
    Chemosphere; 2020 May; 247():125825. PubMed ID: 31927229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer.
    Rajendran R; Garva R; Ashour H; Leung T; Stratford I; Krstic-Demonacos M; Demonacos C
    Int J Oncol; 2013 Jun; 42(6):1961-72. PubMed ID: 23591450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Oligomerization is essential for its C-terminal lysine acetylation.
    Itahana Y; Ke H; Zhang Y
    J Biol Chem; 2009 Feb; 284(8):5158-64. PubMed ID: 19106109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
    Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
    Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53.
    Demma M; Maxwell E; Ramos R; Liang L; Li C; Hesk D; Rossman R; Mallams A; Doll R; Liu M; Seidel-Dugan C; Bishop WR; Dasmahapatra B
    J Biol Chem; 2010 Apr; 285(14):10198-212. PubMed ID: 20124408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.
    Xenaki G; Ontikatze T; Rajendran R; Stratford IJ; Dive C; Krstic-Demonacos M; Demonacos C
    Oncogene; 2008 Oct; 27(44):5785-96. PubMed ID: 18574470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.